DA ZEN THERANOSTICS

Da Zen Theranostics develop a product that can target cancer cells, function as a contrast agent to improve the visibility of cancer cells. It functions as a contrast agent to improve the visibility of cancer cells during diagnostic imaging and deliver a therapeutic drug to destroy cancerous cells. The product will be based on a chemical compound that was created by Dr. Maged Henary, associate professor of chemistry at Georgia State. Henary’s chemical compound, a heptamethine cyanine also known to the scientific community as MHI-148, is already being used internationally in cancer imaging research. The company was founded in 2017 and is based in San Jose, California.